Transgenic mice carrying the SV40 T antigen (TAg) gene, which develop hepatocellular and biliary cell tumors by 4 mo of age, show ductular structures in the neonatal liver. Coexpression of c-myc with TAg increases the extent and persistence of ductular lesions and also accelerates tumor development. To analyze possible links between altered gene expression and cell differentiation and to determine the relationship between the ductular structures and tumor development in these mice, ductular cells in single (TAg) and bitransgenic (TAg X c-myc) mice were characterized for biliary and hepatocellular differentiation, transgene expression, and proliferation activity. The results show that the ductular cells in these transgenic mice have characteristics of biliary cells, including basement membrane formation, positive laminin staining, and bile duct-specific lectin (Dolichos biflorus agglutinin and peanut agglutinin) binding, and characteristics of hepatocytes, including albumin expression and ultrastructural features such as round nuclei with 1 or 2 nucleoli and well-developed cytoplasmic organelles. However, differences in transgene expression and cell proliferation between the ductular cells and nonductular hepatocytes were not apparent. Thus, the ductular cells could not be defined as tumor progenitor cells in these mouse livers. However, this model suggests that manipulation of gene expression can alter differentiation of hepatic parenchymal cells.
1. Araki K, Hino O, Miyazaki J, and Yamamura K (1991). Development of two types of hepatocellular carcinoma in transgenic mice carrying the SV40 large T-antigen gene. Carcinogenesis. 12: 2059–2062.
2.
2. Brenner DA, Buck M, Feitelberg SP, and Chojkier M (1990). Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J. Clin. Invest.. 85: 248–255.
3.
3. Carrier N, Miquerol L, Tulliez M, Lepetit N, Levrat F, Grimber G, Briand P, and Kahn A (1993). Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter. Oncogene. 7: 1413–1422.
4.
4. Cascio S and Zaret KS (1991). Hepatocyte differentiation initiates during endodermal-mesenchymal interactions prior to liver formation. Development. 113: 217–225.
5.
5. Dunsford HA, Maset R, Salman J, and Sell S (1985). Connection of ductlike structures induced by a chemical hepatocarcinogen to portal bile ducts in the rat liver detected by injection of bile ducts with a pigmented barium gelatin medium. Am. J. Pathol.. 118: 218–224.
6.
6. Dyer KR and Messing A (1989). Metal-inducible pathology in the liver, pancreas, and kidney of transgenic mice expressing SV40 early region genes. Am. J. Pathol.. 135: 401–410.
7.
7. Elmore LW and Sirica AE (1991). Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholan-giofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan. Cancer Res.. 51: 5752–5759.
8.
8. Enomoto A, Sandgrcn EP, and Maronpot RR (1998). Interactive effects of c-myc and transforming growth factor a transgenes on liver tumor development in simian virus 40 T antigen transgenic mice. Vet. Pathol.. 35: 283–291.
9.
9. Fanning E and Knippers R (1992). Structure and function of simian virus 40 large tumor antigen. Annu. Rev. Biochem.. 61: 55–85.
10.
10. Hanahan D (1988). Dissecting multistep tumorigenesis in transgenic mice. Annu. Rev. Genet.. 22: 479–519.
11.
11. Hino O, Kitagawa T, Nomura K, Ohtake K, Cui L, Furuta Y, and Aizawa S (1991). Hepatocarcinogenesis in transgenic mice carrying albumin-promoted SV40 T antigen gene. Jpn. J. Cancer Res.. 82: 1226–1233.
12.
12. Kioussis D, Eifcrman F, van de Rijn P, Gorin MB, Ingram RS, and Tilghman SM (1981). The evolution of α-fetoprotein and albumin. II. The structures of the a-fetoprotein and albumin genes in the mouse. J. Biol. Chem.. 25: 1960–1967.
13.
13. Koskinen PJ and Alitalo K (1993). Role of myc amplification and . overexpression in cell growth, differentiation and death. Semin. Cancer Biol.. 4: 3–12.
14.
14. Lemire JM, Shiojiri N, and Fausto N (1991). Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am. J. Pathol.. 139: 535–552.
15.
15. Marcu KB, Bossone SA, and Patel AJ (1992). myc Function and regulation. Annu. Rev. Biochem.61: 809–860.
16.
16. Melhem MF, Meisler AI, Finley GG, Bryce WH, Jones MO, Tribby II, Pipas JM, and Koski RA (1992). Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors. Cancer Res.. 52: 5853–5864.
17.
17. Nagore N, Howe S, Boxer L, and Scheuer PJ (1989). Liver cell rosettes: Structural differences in cholestasis and hepatitis. Liver. 9: 43–51.
18.
18. Palmiter RD and Brinster RL (1986). Germ-line transformation of mice. Annu. Rev. Genet.. 20: 465–499.
19.
19. Rosario MO, Perkins SL, O'brien DA, Allen RL, and Eddy EM (1992). Identification of the gene for the developmentally expressed 70 kDa heat-shock protein (P70) of mouse spermatogenic cells. Dev. Biol.. 150: 1–11.
20.
20. Rüther U, Woodroofe C, Fattori E, and Ciliberto G (1992). Inducible formation of liver tumors in transgenic mice. Oncogene. 8: 87–93.
21.
21. Saber MA, Novikoff PM, and Shafritz DA (1990). Albumin and collagen mRNA expression in normal and analbuminemic rodent liver: Analysis by in situ hybridization using biotinylated probes. J. Histochem. Cytochem.. 38: 199–207.
22.
22. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, and Brinster RL (1989). Oncogene-induced liver neoplasia in transgenic mice. Oncogene. 4: 715–724.
23.
23. Schirmacher P.Held WA, Yang D, Biempica L, and Rogler CE (1991). Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large Tag transgenic mice. Am. J. Pathol.. 139: 231–241.
24.
24. Sepulveda AR, Finegold MJ, Smith B, Slagle BL, DcMayo JL, Shen RF, Woo SLC, and Butel JS (1989). Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human α-1-antitrypsin gene. Cancer Res.. 49: 6108–6117.
25.
25. Sirica AE, Cole SL, and Williams T (1994). A unique rat model of bile ductular hyperplasia in which liver is almost totally replaced with well-differentiated bile ductules. Am. J. Pathol.. 144: 1257–1268.
26.
26. Sirica AE and Williams TW (1992). Appearance of ductuiar hepatocytes in rat liver after bile duct ligation and subsequent zone 3 necrosis by carbon tetrachloride. Am. J. Pathol.. 140: 129–136.
27.
27. Thung SN (1990). The development of proliferating ductular structures in liver disease. An immunohistochemical study. Arch. Pathol. Lab. Med.. 114: 407–411.
28.
28. Ton TT, Foley JF, Flagler ND, Gaul BW, and Maronpot RR (1997). Feasibility of administering 5-bromo-2'-deoxyuridine (BrdU) in drinking water for labeling S-phase hepatocytes in mice and rats. Toxicol. Methods. 7: 123–136.
29.
29. Tulchin N, Ornstein L, Guillem J, O'Toole K, Lambert ME, and Weinstein IB (1988). Distribution of the c-myc oncoprotein in normal and neoplastic tissues of the rat colon. Oncogene. 3: 697–701.
30.
30. Vandersteenhoven AM, Burchette J, and Michalopoulos G (1990). Characterization of ductular hepatocytes in end-stage cirrhosis. Arch. Pathol. Lab. Med.. 114: 403–406.
31.
31. Van Eyken P, Sciot R, and Desmet VJ (1988). A cytokeratin immunohistochemical study of alcoholic liver disease: Evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology. 13: 605–617.
32.
32. Van Eyken P, Sciot R, and Desmet VJ (1989). A cytokeratin immunohistochemical study of cholestatic liver disease: Evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology. 15: 125–135.
33.
33. Watanabe M, Muramatsu T, Shirane H, and Ugai K (1981). Discrete distribution of binding sites for Dolichos biflorus agglutinin (DBA) and for peanut agglutinin (PNA) in mouse organ tissues. J. Histochem. Cytochem.. 39: 779–790.
